Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Sex Offender Registry topic
No spam. Unsubscribe anytime.
Appeals Court hears challenge to registry dissemination where registrant under GPS and probation conditions
Summary
In Doe v. Sex Offender Registry Board, counsel disputed whether the hearing examiner made an individualized, particularized efficacy finding to justify active public dissemination; registrant argued GPS monitoring and exclusion zones undermine the need, while Board counsel said multiple risk factors and a broad victim pool warranted disclosure despite GPS and supervisory measures.
The panel considered 24P1264, Doe v. Sex Offender Registry Board, a contested administrative appeal about whether the Board’s hearing examiner properly found active internet dissemination and public availability of registrant information necessary.
Counsel for the registrant argued the Board failed to make a particularized efficacy finding and said the record lacked evidence showing that GPS monitoring and exclusion zones (and other probation terms) would not mitigate the risk of reoffense. Counsel cited empirical studies on GPS monitoring and exclusion zones suggesting reduced recidivism when zones are enforced, and urged that such conditions must be weighed in the efficacy analysis.
Jessica Blackman, appearing for the Board, said the hearing examiner explicitly considered probationary conditions and gave the registrant mitigating credit but found three high‑risk factors and multiple risk enhancers—broad victim pool, high physical contact, and prior investigations—that justified active dissemination. "He addressed the fact that he's under probation conditions; he has that GPS. He got mitigating credit for it," Blackman said, adding that the remaining risk factors required public notice to protect likely victims.
The justices questioned whether the examiner’s efficacy discussion was sufficiently individualized and whether the presence of temporary GPS monitoring (noted in the record through 2027) should have been integrated more fully into the efficacy analysis. The panel took the arguments and submitted the case for decision.
